However, in contrast to 53BP1 loss, which can restore HR repair to BRCA1-deficient tumors, USP48 loss is not an expected mechanism of tumor resistance in BRCA1 patients as hyper-resection following USP48 loss requires BRCA1 function. This evidence concerns the gene TP53BP1 and neoplasm.